Aura Biosciences, Inc. (AURA) Reports In-Line Q2 EPS

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q2 EPS of ($0.47), in-line with the analyst estimate of ($0.47).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• Waymo Explores Split With Uber - FT
• Civista Bancshares (CIVB) Declares $0.18 Quarterly Dividend; 2.5% Yield
• Tianci International sets up Zimbabwe unit for chromium operations